GlassScriptPhysician profile
David K Speyerer
NPI 1336118686
$2,800.84
in general payments reported to CMS, 2019-2025
24 companies · $603 in 2025
The $603 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $96.66 · 2021: $378 · 2022: $428 · 2023: $465 · 2024: $310 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $402.04 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $364.82 | 2019-2025 | |
| Boston Scientific Corporation | $290.77 | 2019-2023 | Watchman Access System |
| Medtronic Vascular, INC. | $261.62 | 2019 | |
| Davol INC. | $241.19 | 2023-2024 | Phasix Mesh |
| Abbvie INC. | $175.71 | 2019-2023 | Strattice Reconstructive Tissue Matrix Bps |
| Smith+Nephew, INC. | $171.00 | 2022-2025 | Grafix Pl, Renasys Touch |
| Medtronic, INC. | $148.92 | 2021-2024 | Emprint, Barrx |
| W. L. Gore & Associates, INC. | $114.60 | 2022-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Hologic Sales and Service, LLC | $113.35 | 2025 | Magseed |
| Dilon Technologies, INC. | $107.63 | 2024 | Hemoblast Bellows |
| Phathom Pharmaceuticals, INC. | $85.95 | 2024-2025 | Voquezna |
| Acell, INC. | $60.34 | 2020 | |
| Lemaitre Vascular, INC. | $49.04 | 2024-2025 | Artegraft Vascular Graft |
| Kerecis Limited | $45.86 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $29.56 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $27.60 | 2025 | Exparel |
| Merck Sharp & Dohme LLC | $19.74 | 2019 | |
| Coloplast Corp | $18.33 | 2025 | |
| Cardinal Health 200 LLC | $15.54 | 2019 | |
| Conmed Corporation | $15.38 | 2025 | Airseal |
| Kowa Pharmaceuticals America, INC. | $14.73 | 2023 | Seglentis |
| Kci USA, INC. | $13.59 | 2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Nestle Healthcare Nutrition INC. | $13.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Speyerer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.